Cost-effectiveness of TrueNat as compared to GeneXpert as a diagnostic tool for diagnosis of pediatric tuberculosis/MDR Tuberculosis under the National Tuberculosis Elimination Program of India
Meenu Singh(All India Institute of Medical Sciences Raipur), Shivani Saini(Post Graduate Institute of Medical Education and Research), Anil Chauhan(Post Graduate Institute of Medical Education and Research), Ragini Bhatia(Post Graduate Institute of Medical Education and Research), Malaisamy Muniyandi(National Institute of Research in Tuberculosis), Madhuri Devaraju(All India Institute of Medical Sciences Raipur), Pranita Pradhan(Indian Council of Medical Research), Monika Rana(Post Graduate Institute of Medical Education and Research), MalkeetSingh Ghuman(All India Institute of Medical Sciences Raipur), Kulbir Kaur(Post Graduate Institute of Medical Education and Research)
Cited by 3
Related Papers
Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study
|The Lancet|2021|465
Community health workers for non-communicable diseases prevention and control in developing countries: Evidence and implications
|PLoS ONE|2017|300
Prevalence and risk factors for transmission of infection among children in household contact with adults having pulmonary tuberculosis
|Archives of Disease in Childhood|2005|215
Ocular surface manifestations of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
|PLoS ONE|2020|155
Inhaled antibiotics for long-term therapy in cystic fibrosis
|Cochrane Database of Systematic Reviews|2011|128